#Dana-Farber Cancer Institute

Dana-Farber breast cancer researchers performed genomic testing, yielding findings may help personalize treatment in the future.

Dana-Farber researchers explore CAR-T therapy and next generation immunotherapy to target colorectal cancer.

Blogger Megan-Claire Chase morphs into a cancer storyteller who doesn’t have to center whiteness or overanalyze herself.

The Dana-Farber led ALPINE trial looked at the drug in relapsed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

Results of the SORAYA study show antibody-drug conjugate produced remissions in one-third of patients with drug-resistant ovarian cancer.

New study finds racial inequities in access to opioids among older patients with cancer near end of life.

Study finds that risk of adverse side effects from cancer immunotherapy is higher in patients with certain inherited genetic variations.

Scientists map the genetic evolution of chronic lymphocytic leukemia (CLL) to Richter’s Syndrome.

Targeted therapy combo sent chronic lymphocytic leukemia into deep remission in people with high-risk forms of the disease.

The test shows which patients with clonal hematopoiesis, a precancerous state, are more likely to develop blood cancers.

Investigational drug works differently than antibody drugs which are losing effectiveness against the SARS-CoV-2 virus.

Chadwick Boseman, star of the original “Black Panther,” died of colorectal cancer in 2020 at the age of 43.

The collaboration will help advance understanding of the biological basis of pediatric cancers and accelerate cures globally.

Study results support the need for research into the value of monitoring these breast cancer patients with brain imaging tests.

What’s more, receiving SNAP benefits was not enough to address food insecurity for many families of children with leukemia, a study found.

The patient-driven Metastatic Prostate Cancer Research Project releases its first report.